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responsibility of XAbstract The redox behavior of spironolactone (SP) drug in Britton–Robinson (BR) buffer of pH 2–11
was investigated by differential pulse cathodic stripping voltammetry (DPCSV) and cyclic voltammetry
(CV) at hanging mercury dropping electrode (HMDE). At pH 9–10.5, the DPCSV of SP drug showed
two cathodic peaks at 1.15 and 1.38 V at the HMDE vs. Ag/AgCl reference electrode. In the CV, at
pH 9–10, the dependence of the cathodic peak current, Ip,c and peak potential, Ep,c of the second peak
(Ep,c2) on the scan rate (n) and on the depolizer (SP) concentrations was typical of an electrode coupled
(EC) chemical reaction type mechanism. The plot of Ip,c at 1.380 V of the DPCSV vs. SP concentration
at pH 9 was linear over the concentration range of 1.2 10109.6 107 M. The lower limit of
detection (LLOD) and limit of quantiﬁcation (LOQ) of the drug were 1.1 1011 and 4.14 1011 M,
respectively. The method was successfully applied for the analysis of SP residues in industrial wastewater,
in pure form (98.273.1%) and in drug formulations e.g. Aldactones tablet (98.3572.9%).The method
was validated by comparison with HPLC and the ofﬁcial data methods.
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Many drug residues have been found in water and the analysis of
drug residues is the recent area and increasing its importance day
by day [1,2]. Spironolactone (SP) chemically named as 7a-
acetylthio-3-oxo-17a-pregn-4-ene-21,17b-carbolactone acid-g-lac-
tone is a steroid that acts as a competitive antagonist of the
potent endogenous mineral-corticosteroid, aldosterone. It is a drug
in a class of drugs called potassium-sparing diuretics (water pill).
Such drug is widely used to treat high blood pressure, and ﬂuid
retention caused by various conditions, including heart disease. SP
is indicated in the treatment of essential hypertension, edema
associated with congestive heart failure, hepatic cirrhosis withlsevier B.V. All rights reserved.
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of primary aldosteronism [3–6].
Numerous methods e.g. chromatographic [7,8], spectroﬂuori-
metric [9,10], spectrophoto-metric methods using univariate and
multivariate calibration [11] and partial least-squares, multivariate
calibration [12] have been reported for the analysis of SP in drug
formulations, its metabolite canrenone, pure form human serum
and urine. Most of these methods have insufﬁcient sensitivity and
selectivity for the trace levels of the drug in human serum and
urine [11,12]. The low level of SP residues in wastewater samples
was also not compatible with the detection limits of most of these
methods [9–12]. Some of these methods are un-selective and
require careful experimental conditions and time consuming
[11,12].
Polarographic [13] and square-wave adsorptive cathodic
stripping voltammetric (SW-AdSV) [14] have been developed
for SP determination in drug formulations at dropping
mercury electrode (DME) and hanging mercury drop elec-
trode (HMDE) at pH 2–3, respectively. The selectivity and
detection limit of polarographic method [13] are not compa-
tible with the low level of SP residues in wastewater. On the
other hand, in SW-ACSV method [14], peak resolution and
selectivity of the observed cathodic peak at 1.15 V were also
not compatible for analysis of SP residues in wastewater. In
continuation to our previous work on analysis of drug
residues in wastewater [15], this paper reports the redox
behavior of SP drug in an attempt to develop a low cost
and selective differential pulse cathodic stripping voltammetry
(DPCSV) method for analysis of SP residues in wastewater
and drug formulations. HMDE not only exhibited a strong
adsorption towards SP but also provided remarkable stable
and quantitatively reproducible analytical results. HMDE is
safe as long as storage and its disposal is undertaken in a
safe manner. HMDE is the only electrode type sensitive
enough for metal speciation and drug residues in complex
matrices e.g. natural water and wastewaters [16,17].2. Experimental
2.1. Apparatus
A Metrohm 746 VA trace analyzer and 747 VA stand were
used for recording the voltammetric measurements. A three-
compartment (Metrohm) voltammetric electrochemical cell
(10 mL) incorporating HMDE (0.38 mm2) as a working
electrode, double-junction Ag/AgCl, KCl (3.0 M) as a refer-
ence electrode and platinum wire (BAS model MW-1032) as a
counter electrodes was used. Deionized water was supplied
from Milli-Q Plus system (Millipore, Bedford, MA, USA).
A digital pH-meter (model MP 220, Metter Toledo) and a
digital-micro-pipette (Volac) were used for pH measurements
and sample solutions.
2.2. Reagents
All chemicals used were of analytical reagent grade (BDH,
Poole, England). Deionized water was used throughout. SP
drug was obtained from Amriya Rhone-poulenc Pharmaceu-
tical Industries Co. (Alexandria, Egypt). Stock solution of SP
(2.4 103 M) was prepared in a minimum volume of ethanol
and completed to the mark with deionized water. More dilutedconcentrations were prepared by diluting the stock solution
with water. A series of BR buffers (pH 2.311.5) were used as
supporting electrolytes. Aldactones tablets (25 mg/tablet)
were obtained from High Wycombe, England. Low density
polyethylene (LDPE) bottles, Nalgene were used for storage of
wastewater samples from municipal discharge station, Jeddah,
KSA and stored at 20 1C in a refrigerator. The LDPE bottles
were cleaned with hot detergent, HNO3 (2.0 M) and HCl
(0.5 M), and ﬁnally rinsed with water.
2.3. General DPCSV procedures
An accurate volume (10.0 mL) of an aqueous solution con-
taining BR buffer at the required pH (2.111.5) was placed in
the voltammetric cell. The solution was stirred and purged
with N2 gas for 10 min before recording the voltammograms.
The stirrer was then stopped and after 10 s quiescence time,
the DPCSV of the buffer was recorded by applying a negative
going potential scan from 0.0 to 1.5 V vs. Ag/AgCl at a
deposition potential of 0.45 V, accumulation time 60 s,
starting potential 0.0 V, scan rate 60 mV/s and pulse ampli-
tude 50 mV. After measurement of the blank solution, an
accurate concentration (4.8 10-7 M) of SP was placed into
the cell. The solution was stirred, purged with N2 gas for 5 min
and the voltammogram was recorded under the same experi-
mental conditions of the supporting electrolyte. The inﬂuence
of scan rates (n¼500–1000 mV/s), pH and SP concentration
on the cyclic voltammetries (CVs) was also recorded at
HMDE and Pt working electrodes.
2.4. Analytical applications
2.4.1. Analysis of SP in Aldactones tablets
Ten tablets of Aldactones (25 mg SP/tablet) were pulverized
in a mortar, homogenized, accurately weighed and the average
mass per tablet was then determined. An appropriate portion
of the ﬁnally ground material was accurately weighed and
dissolved in the minimum volume of ethanol in a sonicator for
20 min. The test solution was shaken for 15 min in a mechan-
ical shaker to achieve complete dissolution of the active
material and accurately transferred to a 25 mL measuring
ﬂask. The solution was completed to the mark with ethanol
and an accurate volume (20.0 mL) of the clear supernatant
liquor was transferred to the cell containing 10 mL of BR
buffer at pH 9. The amount of the unknown SP drug in the
test solution was then determined with the aid of standard
curve constructed at Ep,c¼1.4 V. Alternatively, the spiking
method was also used as follows: An accurate volume (20 mL)
of the supernatant liquor was transferred to the cell containing
10 mL of BR buffer at pH 9. Under the optimum conditions,
the DPCSVs of the test solution before and after addition of
various volumes of standard SP (10–50 mL in ethanol) were
recorded. The current displayed at 1.40 V by the solution
before and after addition of SP was measured and the
unknown SP concentration was then computed from the
linear plot of the standard addition.
2.4.2. Analysis of SP in water samples
Wastewater samples (200–300 mL) were collected from municipal
discharge station samples, Jeddah city, KSA using a battery
powered, peristaltic pump and immediately ﬁltered through
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bottles (500 mL). An accurate volume (2.0 mL) of the test solution
was transferred to the cell and the solution was completed to
10.0 mL with BR buffer (pH 9). The DPCSVs of the test solution
before and after addition of standard SP (10–50 mL, 0.3 mg/mL
in ethanol) were recorded. The current displayed at 1.38 V vs.
Ag/AgCl electrode was measured and the concentration of the
unknown sample was then determined from the linear plot of the
spiked concentrations of SP vs. the corresponding cathodic peak
current.3. Results and discussion
3.1. Electrochemical behavior of SP drug
In BR buffer over a wide range of pH (2.111.5), the DPCSVs
of SP (5 107 M) at the HMDE vs. Ag/AgCl electrode were
investigated. Representative DPCSVs are shown in Fig.1. TheFig. 1 DPCSVs of SP (4.8 106M) at pH 3(1), pH 9 (2) and
pH 7 (3) at the HMDE vs. Ag/AgCl reference electrode.
Eacc¼0.25 V; tacc¼100 s; scan rate¼60 mV/s and pulse
amplitude of 50 mV.
SchemeDPCSVs of the SP drug solutions at pH lower than 7.0
displayed one reduction peak at 1.05 V (Ep,c1)H assigned to
the reduction of the carbonyl group of pregn-4-ene-21-
carboxylic acid, 7-(acetylthio)-17-hydroxy-3-oxo, g-lactone
(7a, 17a)-, aldactone to pregn-4-ene-21-carboxylic acid, 7-
(acetylthio)-17-hydroxy-3-hydroxy-, g-lactone (7a, 17a)-,
aldactone in two electrons reduction step (2Hþ/2e) [13]
(Scheme 1). In solutions of 7opHo10, the DPCSVs of SP
drug showed two peaks in the range from 1.11 to 1.20 V
(peak I, Ep,c1) and from 1.36 to 1.46 V (peak II, Ep,c2) and
were safely assigned to successive reduction of the SP drug in
two consecutive reduction steps (Hþ/e) [18,19]. On increasing
the solution pH (7 opHo10.5), the values of Ep,c1 and Ep,c2
were shifted cathodically and the plot of pH vs. Ep,c1or
Ep,c2 was linear conﬁrming direct exchange of one H
þ/one
e in two successive single-electrochemical steps leading to
the conversion of CQO group to –CH–OH group [16]. At
pH410.5, peak I disappeared and peak II was ill deﬁned and
affected by adsorption.
The dependence of CV of SP drug at HMDE on pH was
critically investigated. Representative CV at pH 9 at 200 mV/s
scan rate at HMDE vs. Ag/AgCl electrode is shown in Fig. 2.1
Fig. 2 CVs of SP (1.2 104 M) at pH 9.0 at HMDE vs. Ag/
AgCl electrode at 200 mV/s scan rate.
Fig. 3 Inﬂuence of deposition time on the Ip,c2 of SP
(4.8 107 M) at pH 9 at HMDE vs. Ag/AgCl electrode.
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range from 1.38 to 1.42 V, while in solutions of 7
opHo10.3, two cathodic peaks were noticed. On raising
the solution pH (7opHo10.5), the potential of Ep,c1 or Ep,c2
of SP drug at 200 mV/s was shifted to more negative potential
conﬁrming the irreversible nature of the process and the
electrode reaction involves hydrogen ions [18,19]. On the
reverse scan, no anodic peaks were noticed conﬁrming the
irreversible nature of the process.
The inﬂuence of the scan rate, n (502000 mV/s) on the CV
of SP at pH 9 was studied at HMDE. Two peaks I and II were
observed and were assigned to two Hþ/e- consecutive reduc-
tion steps of CQO to –CH–OH group. No anodic peaks were
noticed on the reverse scan indicating the irreversible nature of
the reduction process [19]. On increasing the scan rate, Ep,c1
and Ep,c2 at pH 7–9 were shifted cathodically conﬁrming the
irreversible nature of the reduction steps [19]. The plots of Ip,c2
vs. n increased linearly conﬁrming the adsorption process of
SP at HMDE [19].
The variation of the current function (Ip,c/n
1/2) with scan
rate is an important diagnostic criterion for distinguishing
between the ECE (chemical reaction coupled between two
charge -transfer processes) and EE (two successive one-
electron charge-transfer processes) [19] type mechanisms.
The plot of Ip,c/n
1/2 vs. n of peak I increased linearly on
raising the n indicating that the observed behavior does not
favor the EC mechanism. This ﬁnding may be taken as an
indication of the CE mechanism with an irreversible reduction
step of the drug [19,20]. The observed behavior may possibly
be explained by considering that the protonation reaction is
very fast or virtually complete, so that, the electrode reaction
appears to be of the ECE type at the scan rates used in the
present investigation. In the CV, a small reduction peak
current at high n corresponding to peak I was noticed. Thus,
it can be concluded that, the reduction step undergoes a
very rapid follow-up chemical reaction [13,14]. The depen-
dence of the CV response on analyte concentration at pH 9.0
showed no signiﬁcant changes on the cathodic current of
the observed cathodic peak at 1.20 V, indicating that the
electrochemical process is a typical of ECE type electro-
chemical mechanism [19].
The value of the electron transfer coefﬁcient (a) involved
in the rate determining step was calculated employing the
following equation [21]:
DE=Dlog n¼29:58=ana ð1Þ
where na is the number of electron transfer in the rate determining
step. Assuming na is equal 1 or 2, the computed values of a from
the linear plots of linear plots of log n vs. Ep,c1 of peak I and log n
vs. Ep,c2 of peak II were found higher than 0.6 conﬁrming the
irreversible nature of the observed reduction steps [13,20]. This
trend is also indicative of kinetic complications in the electrode
process and the reduction process comprises several reactions
including adsorption [13,19].
The surface coverage (G) of the electroactive species was
calculated from the CVs using the following equation [21]:
Ip,c¼n2F2AGu/4RT (2)
where, n¼ number of electron, A¼area of the electrode
surface, cm2, T is the absolute temperature and R is the gas
constant. For n¼2, a value of G was found equal 77 106 M
encouraging application of the DPCSV for SP determination.3.2. Analytical parameters
Preliminary DPCSV investigation has shown that, the current
of peak I was independent from the SP concentration;
however, the Ip,c2 of peak II is dependent. The high degree
of surface coverage of SP onto the HMDE and sensitivity of
cathodic peak II towards SP concentration encouraged study-
ing the analytical parameters that control the peak current of
peak II using DPCSV procedures. Thus, peak I was not
selected in the next work, while the inﬂuence of analytical
parameters that control cathodic peak current of peak II was
critically studied. The plot of pH vs. Ip,c2 (Fig. 1) revealed
that, Ip,c2 reached the maximum at pH 9–10.3 and in this
pH range, the cathodic peak was sharp and symmetric.
Thus, in the subsequent work, the solution pH was adopted
at pH 9–10.
The effect of the adsorption time (tad) on the collection and
stripping procedure of SP drug at the HMDE was tested in the
range of 30–180 s. The maximum peak current was achieved
at tad of 60 s (Fig. 3) for SP solution (5 107 M). At
accumulation time greater tad than 180 s, the peak current
leveled off because of adsorption saturation of SP drug at the
HMDE (Fig. 3). Because of the strong adsorption of SP drug
at the surface of the HMDE at the equilibrium time, the plot
of tad vs. Ip,c of peak II did not passed through the origin
[19,20].
The effect of deposition potential (Ead.) on the peak current of
peak II (1.38 V) at HMDE vs. Ag/AgCl reference electrode
was studied. The maximum peak current was achieved at
Ead¼0.45 V. At deposition potentialo0.45 V, the back-
ground current gradually deteriorates (Fig. 4). Thus, a
deposition potential of 0.45 V was selected in the next work.
The effect of n (1060 mV/s) at pH 9–10 on the Ip,c2 of peak
II at the HMDE was tested at the optimum tad and Ead. At
scan rate of 60 mV/s, the Ip,c2 increased steadily on raising the
n and best background, sensitivity and peak resolution were
achieved. Thus, a 60 mV/s scan rate was adopted in the
next work.
The effect of pulse amplitude (90 to 100 mV) on the
DPCSV peak under the optimal conditions was studied. The
peak current increased steadily on decreasing pulse amplitude
Fig. 4 Inﬂuence of deposition potential on the Ip,c2 of SP
(4.8 107 M) at pH 9 at HMDE vs. Ag/AgCl electrode.
Fig. 5 DPCSVs of SP in BR buffer of pH 9 at HMDE vs. Ag/
AgCl reference electrode at various SP concentrations. Condi-
tions: Eacc¼0.45 V, tacc ¼60 s, n¼ 60 mV=s, pulse amplitude
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current were achieved. Thus, in the next work a pulse
amplitude of 50 mV was chosen. The inﬂuence of varying
the starting potential (0.0 to 1.0 V) on the DPCSV peak
current at 1.40 V was evaluated at HMDE. At starting
potential o0.0 V, the value of Ip,c2 decreased due to the prior
reduction of SP drug at a starting potential close to 0.2 V.
The maximum peak current was achieved at 0.0 V, hence, a
starting potential of 0.0 V was selected in the next work.50 mV and 0.0 V starting potential.3.3. Figure of merits
Under the optimum experimental conditions of pH 9–10,
deposition time 60 s, deposition potential 0.45 V, pulse
amplitude 50 mV, starting potential 0.0 V and scan rate
60 mV/s, the DP CSV of SP showed that, the Ip,c1 at 1.1 V
was not sensitive and independent on SP concentration, while
the Ip,c2 at 1.40 V vs. Ag/AgCl increased linearly on
increasing the drug concentration in the range from
1.2 1010 to 9.6 107 M (Fig. 5). Above 9.6 107 M,
the Ip,c2 tended to level off because of the adsorption
saturation with the following a regression equation:
Ipc2ðnAÞ ¼ 1:71C mMð Þ þ 3E14 R2 ¼ 0:995
 
According to International Union of Pure and Applied
Chemistry (IUPAC) [22], the lower limit of detection (LLOD¼
3Sy/x/b) and limit of quantiﬁcation (LOQ¼10Sy/x/b), where Sy/x
is the standard deviation of y-residual and b is the slope of
the calibration plot of SP, were found equal 1.1 1011 and
4.14 1011 M. A relative standard deviation (RSD) of SP
at 8.5 107 M was found equal 2.39% (n¼5). The main
analytical features of the proposed method were compared
with the reported CdSe quantum dots as luminescent probes
[9], polarographic [13] and square wave DP CSV [14]
methods for SP determination. The ﬁgures of merits (linear
dynamic range, LLOD, LOQ and RSD) of the developed
DPCSV method are better than those of the HPLC [7],
polarographic [13], SW-AdSV [14] and ofﬁcial [23] methods.
Although the present method requires higher overvoltage
(1.4 V) which is more liable to be interfered by other redoxspecies than the SW-AdSV (1.0 V) [14], the present method
is selective, rapid, and shows excellent ﬁgures of merits.3.4. Selectivity
The selectivity of the DPCSV method was estimated by adding
various excipients, diluents and active ingredients e.g. magne-
sium stearate, talcum powder, sodium lauryl sulfate, sucrose,
glucose, lactose maltose, starch and mannitol used in pharma-
ceutical formulations. Each excipient (0.4–0.6 g) was added
according to the manufacturer’s batch formula to known
concentration of SP (9.6 107 M). The tolerable limit was
deﬁned as the concentration of the excipient causing a
deviation in the range73.0% of the peak current at 1.45 V vs.
Ag/AgCl of SP solution under the optimum condition. No
signiﬁcant changes on the magnitude of Ip,c2 (nA) by more
than 73.0% were noticed. Thus, the method is free from the
tested excipients. A series of SP solutions (9.6.0 107M)
containing atenolol, metoprolol, amiloride, aspirin, or qui-
nine individually at concentration of 9.6 107 M were also
tested. Amiloride drug interfered seriously at a concentration
of amiloride 100 times SP. This behavior is most likely
attributed to the competitive adsorbability of amiloride with
SP drug on the surface of the HMDE at the optimum pH.3.5. Analytical application
3.5.1. Analysis of SP in pure- and dosage form
The method was applied to the analysis of SP in pure form
and in pharmaceutical preparations via calibration plot and
Table1 Determination of SP (n¼3) in pure form and in dosage form (Aldactone, 25 mg/tablet) by direct calibration (A) and the
standard addition (B) of the DPCSV method, HPLC (C) and the ofﬁcial titrimetric (D) procedures.a
Drug product A B C D
Pure drug (%) 97.472.2 101.472.4 97.9 71.7 98.472.9
RSD(%) 2.56 2.1 2.3 3.1
t-Valuea 1.63 (2.31) 1.54 (2.31)
F-valueb 1.29 (2.31) 1.75 (2.31)
2.20 (6.39) 2.7 (6.39)
1.18 (6.39) 2.64 (6.39)
Aldactone tablet 97.972.4 101.271.9 98.571.7 98.571.7
RSD – 73.66 72.93 73.85
aAverage recovery7ts/n1/2; n¼3.
bThe theoretical ﬁgures of t- and F-values at P¼0.05 are given in parentheses.
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Table 1. These results were validated by comparison with the
standard HPLC [7] and the ofﬁcial methods [23] data follow-
ing the method of validation [24]. A recovery of 97.3572.2%,
with RSD of72.56 in pure drug was achieved via direct linear
plot in good agreement with the results obtained via the
standard addition procedure (101.472.4%, RSD¼72.10).
These results were successfully validated by comparison with
standard HPLC (97.971.7%, RSD¼72.3) and the ofﬁcial
(98.472.9%, RSD¼73.1) [7,23,24] methods. The F and
student t- tests showed no signiﬁcant difference between the
developed and these methods [7,23–25].
The results of analysis of SP in Aldactone (Searle) tablet
(25.0 mg/tablet) by the developed method via calibration
plot and standard addition are given in Table 1. The results
of the present method (24.4670.9 mg/tablet, n¼3) are in
agreement with the claimed value (25.0 mg/tablet), HPLC
(24.670.72 mg/tablet) [7] and the ofﬁcial (25.270.97 mg/
tablet) [23,24] methods. At the 95% probability, the Student’s
t- and F tests showed no signiﬁcant differences between the
developed DPCSV, HPLC [7] and the ofﬁcial [23,24] methods
(Table 1).
3.5.2. Analysis of drug in wastewater
The sensitivity of the developed DP CSV encourages determi-
nation SP residues in tap and industrial wastewater samples by
the spiking method. Various volumes (10–50 mL) of standard
SP (0.3 mg/mL in ethanol) were added to wastewater sample
and analyzed as described in the experimental section. The
recovery percentage of the developed method (101.8072.9%)
was close to the results obtained by the ofﬁcial titrimetric
method (98.672.7%) [23,24] for SP drug added. The t- (1.78)
and F- (1.25) tests at 99% conﬁdence levels did not exceed the
theoretical ones 2.31 and 6.39, respectively, conﬁrming the
accuracy of the DP CSV method.4. Conclusion
The developed method provides an excellent alternative
approach for the determination of SP in comparison with
HPLC, polarographic and voltammetric and the ofﬁcial
methods. The sensitivity and selectivity of the developed
procedures for the determination of SP in various matricescould be improved by the preconcentration from large sample
volumes onto solid sorbent packed column followed by elution
and subsequent analysis. Work is continuing for the applica-
tion of on-line stripping analysis of SP in serum, blood and
environmental samples.
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